Treatment of psoriatic arthritis complicated by systemic lupus erythematosus with the IL-17 blocker secukinumab and an analysis of the serum cytokine profile-Reference-Cited by-同舟云学术

Treatment of psoriatic arthritis complicated by systemic lupus erythematosus with the IL-17 blocker secukinumab and an analysis of the serum cytokine profile

Published:2020-02-03 Issue:2 Volume:4 Page:181-185
ISSN:2472-5625
Container-title:Modern Rheumatology Case Reports
language:en
Short-container-title:Modern Rheumatology Case Reports

Author:

Sato Kojiro¹^ORCID,Aizaki Yoshimi¹,Yoshida Yoshihiro¹,Mimura Toshihide¹

Affiliation:

1. Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/24725625.2020.1717741

Reference20 articles.

1. Psoriasis

2. Differential efficacy of biologic treatments targeting the TNF-α/IL-23/IL-17 axis in psoriasis and psoriatic arthritis

3. Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis

4. Possible paradoxical occurrence of inflammatory arthritis in patients with psoriasis treated with biologics: findings in the Biobadaderm cohort

5. Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response of Psoriasis with Systemic Lupus Erythematosus to Secukinumab: A Case Report and Review of the Literature;Clinical, Cosmetic and Investigational Dermatology;2023-12

2. Molecular consideration relevant to the mechanism of the comorbidity between psoriasis and systemic lupus erythematosus (Review);Experimental and Therapeutic Medicine;2023-08-29

3. Is Th17-Targeted Therapy Effective in Systemic Lupus Erythematosus?;Current Issues in Molecular Biology;2023-05-15

4. Molecular treatment trajectories within psoriatic T lymphocytes: a mini review;Frontiers in Immunology;2023-05-12

5. The role of interleukin-17 in spondyloarthropathies and systemic lupus erythematosus: Two clinical cases in real;Global Journal of Medical and Clinical Case Reports;2022-01-19